Porphyria cutanea tarda and the pill: case report

Area of Science:

• Hepatology
• Endocrinology
• Dermatology

Background:

• Porphyria cutanea tarda (PCT) is the most common porphyria, characterized by skin lesions and porphyrin accumulation.
• Estrogenic oral contraceptives are known to potentially exacerbate certain medical conditions.

Purpose of the Study:

• To describe a case of porphyria cutanea tarda (PCT) in a patient using oral contraceptives.
• To discuss the implications for porphyrin metabolism and associated symptoms.

Main Methods:

• Case report detailing clinical presentation and treatment.
• Review of existing literature on porphyria cutanea tarda and oral contraceptive interactions.

Main Results:

• The patient developed symptoms consistent with PCT during oral contraceptive use.
• Discontinuation of the oral contraceptive led to remission of PCT symptoms.
• Abdominal pain and psychological changes were noted and resolved with treatment.

Conclusions:

• Oral contraceptive use can be a precipitating factor for porphyria cutanea tarda in susceptible individuals.
• Understanding the link between hormonal therapy and porphyrin metabolism is crucial for patient management.
• Early recognition and cessation of the offending agent can lead to favorable outcomes.